Robin Toft
Senior Advisor
Professional Profile
Robin Toft is a Global Life Science & Boardroom Diversity Leader at ZRG Partners. Robin founded Toft Group, a life science search firm with $10 million in revenue which was acquired by ZRG Partners in 2019. Robin specializes in placing diverse (by age, gender, and race) C-level executives, and board directors. She has always believed that companies with diverse executive teams and boards have a competitive advantage in hiring, and are also more innovative and profitable. Prior to founding Toft Group, Robin served as SVP Commercial Operations for Roche, and had a successful industry career in sales.
Robin runs a busy desk at the intersection of biotech, precision medicine, and healthcare high tech, with a focus on commercial stage rapidly growing companies. She has a passion for start-ups and routinely assists VC-backed and entrepreneurial early to mid-stage companies to build leadership teams. Life Science investors served include: 5am Ventures, Ampersand Ventures, Canaan Partners, Cota Capital, Domain, Forward Ventures, Interwest, Khosla Ventures, Kleiner Perkins, Maravai LifeSciences, Mohr Davidow Ventures, Merck Global Health Ventures, NorthPond Ventures, NEA, OrbiMed, Prospect Venture Partners, RA Capital, Safeguard Scientific, Sanderling, Sequoia Capital, Section 32, Sofinnova, SR One, Third Rock Ventures, Telegraph Hill Partners, TPG Ventures, Venrock, and Versant Ventures. Additional investors served in the digital health space include: Ally Bridge Group, 7Wire, 8VC, B Capital, BCBS Venture Partners, Carlyle, Casdin Capital, Codex Capital, Droia, Echo Health Ventures, Foresite Capital, Founders Fund, Google Ventures, HIG BioHealth Partners, Intel Capital, Invus, Menlo Ventures, Octopus Ventures, ORI Capital, Orix Capital, Pontifax, Rustic Canyon Partners. Social Capital Ventures, SV Health, Taiho Ventures, VC Builders, Vida Ventures, Wellington Management and Wu Capital.
Robin is the Author of Ignite Your Board Career, WE CAN: The Executive Women’s Guide to Career Advancement, and Ignite Your Board Career: Board IQ Playbook. She speaks routinely to executive women’s organizations. She co-founded We Can Rise, Inc. to inspire career women to confidently reach their potential collaborating - with men- to build healthier companies that change the world.
Robin serves as Vice Chairman of the Board of American Cancer Society’s CEOs against cancer, is Board Director of T2 Biosystems in Boston, Syapse in San Francisco, California Life Sciences (CLS), The Clearity Foundation, and We Can Rise to accelerate advancement of women worldwide.
